Yogeeta B. Jadhav
Senior Technical Specialist 鈥 Chemistry
Yogeeta B. Jadhav
Senior Technical Specialist 鈥 Chemistry
Dr. Yogeeta Jadhav thrives on applying her extensive knowledge of chemistry and leveraging over 15 years of patent practice experience to assist clients in protecting their inventions. Her wide-ranging experience includes preparation and prosecution of patent applications; patentability assessment; freedom-to-operate, non-infringement, and patent validity analysis; and due diligence matters spanning a broad spectrum of technologies, including pharmaceuticals, nutraceuticals, chemical compositions and processes, small molecules, vaccines, antibody-drug conjugates, drug formulations, cannabis, food and beverages, personal care products, batteries, pet products, coating and polymers. She is a member of the Firm鈥檚 Intellectual Property Department, Health Care & Life Sciences Sector, and Chemical, Biotechnology & Pharmaceutical Practice.
Prior to joining 麻豆传媒, Yogeeta was a patent scientist at Sandoz India Pvt Ltd, the generic pharmaceuticals division of Novartis. She also worked as a research manager with Lupin Limited, a leading global pharmaceutical company based in Pune, India, where she assisted attorneys with respect to drafting, filing, and prosecuting patent applications; conducting infringement analysis; and evaluating new drug molecules for their patent situation, chemistry, process and technical complexity, and polymorph issues.
After completing her doctoral degree, Yogeeta was a postdoctoral fellow at Monash University in Australia, where she continued her doctoral research focused on the development of a catalytic process for the hydration of aromatic epoxides and phase transfer catalytic reactions in the organic process industry, including agrochemicals, pharmaceuticals, and perfumes, respectively. Her research has resulted in several journal publications and has been presented at national and international conferences.
Presentations and Publications
- 鈥淩ole of the Omega Phase in the Analysis and Intensification of Solid-Liquid Phase-Transfer-Catalyzed Reactions,鈥 Jadhav, Y.; Yadav, G., Langmuir, 18 (16), 5995鈥6002, 2002
- 鈥淪ynthesis of 2, 4-dichlorophenoxyacetic acid: Novelties of Kinetics of Inverse Phase Transfer Catalysis,鈥 Jadhav, Y.; Yadav, G., J. Mol Catalysis A: Chemical, 184 (1鈥2), 151鈥160, 2002
- 鈥淜inetics and Modeling of Liquid-Liquid Phase Transfer Catalyzed Synthesis of p-chlorophenyl acetonitrile: Role of Co-catalyst in Intensification of Rates and Selectivity,鈥 Jadhav, Y.; Yadav, G., J Molecular Catalysis A: Chemical, 192, 41鈥52, 2003
- 鈥淐ascade Engineered Phase Transfer Catalysis: A Novel Concept in Green Chemistry,鈥 Jadhav, Y.; Yadav, G., Clean Tech. Environ. Policy, 6(1), 32鈥42, 2003
- 鈥淣ovelties of Solid-Liquid Phase Transfer Catalyzed Synthesis of I-isopropyl-p-chlorophenyl acetonitrile from pchlorophenyl acetonitrile,鈥 Jadhav, Y.; Yadav, G., Organic Process Research & Development, 7(4), 588-598, 2003
- 鈥淣ovelties of Kinetics and Mechanism of Liquid-Liquid Phase Transfer Catalyzed Reduction of p-nitroanisole to p-anisidine,鈥 Jadhav, Y.; Yadav, G.; Sengupta, S., Chem. Engg. Science, 55(12), 2681鈥2689, 2003
- 鈥淪electively Engineered Phase Transfer Catalysis in the Synthesis of Fine Chemicals: Reactions of p-chloronitrobenzene with sodium sulphide,鈥 Jadhav, Y.; Yadav, G.; Sengupta, J. Molecular Catalysis A: Chemical, 200, 117鈥129, 2003
Languages
- Hindi (fluent)
- Marathi (native)
麻豆传媒 Represents Verona Pharma in $10B Acquisition by Merck
USPTO Publishes Drug Patent and Exclusivity Study Report
Federal Circuit Considers Patentability of Overlapping Ranges
USPTO Discusses Duty of Disclosure and Duty of Reasonable Inquiry
USPTO-FDA Listening Session 鈥 Voices from Patient and Patent Advocates